Understanding a key cell channel in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how a specific channel in your cells (called the KATP channel) affects blood sugar control in people with and without type 2 diabetes. It aims to understand why some people develop diabetes and how to better treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- Your body mass index (BMI) is between 18.5 and 50, depending on your group.
- Your blood sugar and A1C levels fall into one of these categories: normal, mildly high, or diabetic (if you have type 2 diabetes, your A1C must be between 6.5% and 9.5%).
- You are not taking more than 0.5 units of insulin per kilogram of body weight each day, and your diabetes medication has not changed in the last 3 months.
- Your weight has been stable (no more than 2% change) in the last 2 months.
- You do not use tobacco regularly, drink heavily (more than 2–3 drinks per day), or take certain medications like steroids or blood thinners (unless they can be stopped temporarily).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how growth hormone affects insulin-making cells in people at risk for type 2 diabetes. It may help explain why some people with a family history of diabetes develop the condition.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This Phase 2 study tests how certain channels in the brain help control how your body makes and releases sugar (glucose). It may help explain blood sugar problems in people with type 2 diabetes and healthy volunteers.
This trial tests how two diabetes medications, SGLT2i and pioglitazone, affect ketone production in people with type 1 diabetes. It aims to find new ways to improve blood sugar control.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This study tests two medications—pioglitazone (a pill) and tirzepatide (an injection)—in people with type 2 diabetes who have a normal body weight. It aims to find which treatment works better for this specific group.
Hear when a new Obesity and Type 2 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.